Since a common feature of many of the active inflammatory pathways in psoriasis use the Janus kinase/Signal transducer and activator of transcription (JAK/STAT) system, more recent studies take advantage of these findings to establish small molecule JAK inhibitors for treatment of psoriasis (36). The gene discussed is SOAT1; the disease is psoriasis.